Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy

被引:10
|
作者
Mella, Alberto [1 ]
Deambrosis, Ilaria [2 ]
Mingozzi, Silvia [1 ]
Colla, Loredana [1 ]
Burdese, Manuel [1 ]
Giaretta, Fulvia [2 ]
Bruno, Stefania [2 ,3 ]
Camussi, Giovanni [3 ]
Boaglio, Elena [1 ]
Dolla, Caterina [1 ]
Clari, Roberta [1 ]
Biancone, Luigi [1 ]
机构
[1] Univ Turin, Div Nephrol Dialysis & Transplantat, Dept Med Sci, Citta Salute & Sci Hosp, I-8810126 Corso, Italy
[2] Citta Salute & Sci Hosp, Lab Nephrol & Immunopathol, Turin, Italy
[3] Univ Turin, Dept Med Sci, Turin, Italy
关键词
DISEASE-ACTIVITY; RECEPTOR; AUTOANTIBODIES; PROGRESSION; CELLS;
D O I
10.1038/s41598-020-73335-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999-16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+score in 6/27-22.2%, 2+in 4/27-14.8%, 3+in 2/27-7.4%, 4+in 5/27-18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+was statistically correlated with the absence of remission and Ab anti-PLA(2)R+(p<0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Rituximab for idiopathic membranous nephropathy
    Remuzzi, G
    Chiurchiu, C
    Abbate, M
    Brusegan, V
    Bontempelli, M
    Ruggenenti, P
    LANCET, 2002, 360 (9337): : 923 - 924
  • [32] RELAPSING IDIOPATHIC MEMBRANOUS NEPHROPATHY
    MANOS, J
    SHORT, CD
    ACHESON, EJ
    DYER, P
    LAWLER, W
    MALLICK, NP
    WILLIAMS, G
    CLINICAL NEPHROLOGY, 1982, 18 (06) : 286 - 290
  • [33] Treatment of idiopathic membranous nephropathy
    Julia M. Hofstra
    Fernando C. Fervenza
    Jack F. M. Wetzels
    Nature Reviews Nephrology, 2013, 9 : 443 - 458
  • [34] Therapy of idiopathic membranous nephropathy
    Rostoker, G
    Weil, B
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 6 (01): : 7 - 27
  • [35] TREATMENT OF IDIOPATHIC MEMBRANOUS NEPHROPATHY
    PONTICELLI, C
    NEPHRON, 1987, 46 (04): : 402 - 403
  • [36] THERAPY OF IDIOPATHIC MEMBRANOUS NEPHROPATHY
    PONTICELLI, C
    ZUCCHELLI, P
    PASSERINI, P
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1987, 9 (04): : 431 - 440
  • [37] EFFECT OF ENALAPRIL (EN) ON URINARY PROTEIN EXCRETION IN IDIOPATHIC MEMBRANOUS NEPHROPATHY (IMN)
    MOSCONI, L
    RUGGENENTI, P
    SANGALLI, F
    VENDRAMIN, G
    MORIGGI, M
    MECCA, G
    REMUZZI, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 428 - 428
  • [38] Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
    Ziyong Tang
    Yue Wang
    Liyuan Tao
    Yanhong Guo
    Yimu Zheng
    Danxia Zheng
    BMC Nephrology, 20
  • [39] Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy
    Hofstra, Julia M.
    Deegens, Jeroen K. J.
    Steenbergen, Eric J.
    Wetzels, Jack F. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (10) : 3160 - 3165
  • [40] Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy
    Endo, M
    Fuke, Y
    Tamano, M
    Hidaka, M
    Ohsawa, I
    Fujita, T
    Ohi, H
    NEPHRON CLINICAL PRACTICE, 2004, 97 (04): : C147 - C153